FdaApplication
BLA 125856
Identifiers
- fda_app_no: BLA125856
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Gene Therapies, Inc. |
| application_type | BLA |
| approval_date | 2025-11-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ITVISMA | — | 4x10^13VG/ML | Injection |
1 product